Related Experiment Video
Updated: May 12, 2026

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
Published on: September 23, 2015
Decoding Prolonged Residence Time of 5-HT2A Receptor Antagonists: Insights from Ritanserin Derivatives
Szymon K Kordylewski1, Kinga Kurowska1, Krystyna Nędza1
1Maj Institute of Pharmacology Polish Academy of Sciences, Smetna 12, 31-343 Krakow, Poland.
Abstract:
The lifetime of a ligand-receptor complex has been suggested to play an important role in compound activity and sustained pharmacological action. However, due to the multitude of other factors considered during optimization, this aspect is often neglected in the early stages of drug design and development. Consequently, data on ligand residence time (RT) remain limited, and the molecular determinants underlying prolonged binding are not fully understood. In this study, we focused on ritanserin, a known 5-HT2A receptor (5-HT2AR) antagonist with an RT of 68 min. By modifying its structure, we synthesized a series of derivatives with varying RT, which was determined in vitro. Comprehensive molecular modeling analyses, including docking and molecular dynamics simulations, enabled us to propose a set of key receptor-ligand contacts contributing to prolonged binding. Both conventional molecular dynamics and enhanced sampling approaches (metadynamics and random-accelerated molecular dynamics) were applied to the native and mutant receptors, providing in-depth insights into the determinants of long ligand occupancy at the 5-HT2AR. The study indicated that prolonged RT is associated with, for example, stable and geometrically optimized π-π interactions with a hydrophobic aromatic cluster (Trp3366.48 and Phe3406.52, in particular). To our knowledge, this represents the first such a comprehensive study of its kind, offering novel hypotheses that may guide the design of new 5-HT2AR ligands with prolonged duration of action.
Related Concept Videos
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Desensitization and Tachyphylaxis
Several...
Antidepressant Drugs: MAOIs and Other Agents
Antipsychotic Drugs: Typical and Atypical Agents
GPCR Desensitization
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
